课题基金 / 基金详情

SERUM TYROSYL KINASES IN HUMAN NEOPLASIA

SERUM TYROSYL KINASES IN HUMAN NEOPLASIA
人类肿瘤中的血清酪氨酰激酶
批准号:
3178905
负责人:
GAIL M CLINTON
金额:
$16.43万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1991-03-31

项目摘要

项目成果

GAIL M CLINTON的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tyrosine-specific protein kinase is an enzyme activity associated with several oncogene proteins and growth factor receptors. Proteins with this rare activity have been shown to cause tumors in animals and to be amplified in some human tumors. Our preliminary studies indicate that serum is an easily obtained human specimen which can be used to investigate tyrosyl kinases expressed in normal and neoplastic cells in the intact organism. We have found that serum tyrosyl kinase activity is developmentally expressed in humans and that the activity is elevated in sera from some patients with neoplastic disorders. Our aims are: (1)\to identify serum tyrosyl kinases that may be associated with human neoplastic disorders; (2)\to identify serum tyrosyl kinases that may be used in cancer diagnostic tests; and (3)\to identify tyrosyl kinases that are associated and different stages of human development. To achieve these aims we will fractionate and characterize the different tyrosyl kinase species in human serum. The relationship of serum enzymes with growth factor receptors and oncogene proteins will be established by biochemical comparisons and by reactivity to specific immunological reagents. Those serum tyrosyl kinases that are unrelated to previously identified enzymes will be autophosphorylated to identify the active subunit molecular weights, tested for glycosylation, and used to prepare antibodies. Comparisons will be made of the specific tyrosyl kinases and their levels of activity in sera from different age groups to define the species that are developmentally expressed and in sera from patients with different neoplastic disorders to define the species that are associated with neoplasia. Correlations of the levels of the enzyme with the stage of the disease will indicate the value of the tyrosyl kinase assay in cancer diagnosis. (1)
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells.
人类乳腺癌细胞释放与 HER-2 原癌基因产物相关的可溶性蛋白质。
DOI: --
发表时间: 1991
期刊: Oncogene
影响因子: 8
作者: [Lin,YZ, Clinton,GM]
通讯作者: Clinton,GM
Antibodies against highly conserved sites in the epidermal growth factor receptor tyrosine kinase domain as probes for structure and function.
针对表皮生长因子受体酪氨酸激酶结构域中高度保守位点的抗体,作为结构和功能的探针。
DOI: 10.1021/bi00068a025
发表时间: 1993
期刊: Biochemistry
影响因子: 2.9
作者: [Brown,NA, Compton,LA, Clinton,GM]
通讯作者: Clinton,GM
Insulin and epidermal growth factor stimulate phosphorylation of p185HER-2 in the breast carcinoma cell line, BT474.
胰岛素和表皮生长因子刺激乳腺癌细胞系 BT474 中 p185HER-2 的磷酸化。
DOI: 10.1016/0303-7207(90)90004-r
发表时间: 1990
期刊: Molecular and cellular endocrinology
影响因子: 4.1
作者: [Lin,YZ, Li,SW, Clinton,GM]
通讯作者: Clinton,GM
The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase.
前列腺细胞的表皮生长因子受体被前列腺特异性磷酸酪氨酰磷酸酶去磷酸化。
DOI: 10.1128/mcb.8.12.5477-5485.1988
发表时间: 1988
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Lin,MF, Clinton,GM]
通讯作者: Clinton,GM
TRUNCATED HER 2/NEU PROTEIN IN BREAST CANCER
TRUNCATED HER 2/NEU PROTEIN IN BREAST CANCER
TRUNCATED HER 2/NEU PROTEIN IN BREAST CANCER
TRUNCATED HER 2/NEU PROTEIN IN BREAST CANCER